Igenesis
PrivateLast Round
Series B
Extension
Aug 26, 2021
Total Funding Raised
$85.4M
Company Overview
Igenesis is a biotechnology company that develops and manufactures automated PCR analysis platforms, medical diagnostic tools, and nucleic acid extraction kits for healthcare and forensic applications.
Sector
Healthcare & Life Sciences
Verticals
Medical Devices, Biotech Equipment, Precision Medicine, Biotechnology
Business Model
B2B
Customer Profile
Hardware Sales, Usage-Based SaaS
AI Layer
Non-AI
Keywords
Historical Pricing
Historical view of private secondary pricing and transaction trends.
Igenesis Comparables
Compare Igenesis with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| Ustar Biotechnologies (Hangzhou) Ltd. | 86% | |
| Coyote Bioscience Co., Ltd. | 84% | |
| Daan Gene Co., Ltd. | 76% |
Igenesis Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Series B Extension | Aug 26, 2021 | ||||
| Series B | Jun 15, 2021 |
Igenesis Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| Huimei Capital | Series B Extension |
Market signals
Structured signals derived from secondary market and firmographic data.
- Mar 1, 2026
Monthly visitors increased 627% MoM, reaching 5.7K.
Igenesis Filings
Explore SEC and related filing metadata, where available.
| Type | Date | Amount Offered | Amount Sold | Filing | Pages | Download |
|---|
Filing documents are not displayed on this public page. Request access to learn about available coverage.
Request accessFrequently Asked Questions
Common questions about Igenesis's valuation, stock price, and market status.
Is Igenesisbio a public or private company?
Igenesisbio is a private company.
What is the current stock price of Igenesisbio?
Igenesisbio is a private company with no public stock price. No recent secondary market data is available.
How much is Igenesisbio worth (valuation)?
Valuation information for Igenesisbio is not publicly available.
Can I buy Igenesisbio stock?
Igenesisbio shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors. Visit https://www.caplight.com to learn more.
When was Igenesisbio's last funding round?
Igenesisbio's most recent funding round was Series B Extension on August 26, 2021.
Who are the main investors in Igenesisbio?
Key investors in Igenesisbio include Huimei Capital.
Will Igenesisbio IPO soon?
No public IPO plans have been announced for Igenesisbio.
How can I track Igenesisbio secondary market activity?
Caplight tracks bids, offers, and trades for private companies. Visit https://www.caplight.com to monitor Igenesisbio's secondary market activity and sign up for updates.